Pakistan-China pharma conference ends with $850m agreements
• Health minister says 16 contracts, 80 MoUs finalised • Agreements include 18 deals related to herbal medicines ISLAMABAD: Pakistan’s agreements with Chinese companies reached $850 million on the concluding day of the two-day Pakistan-China Pharmaceutical and Healthcare B2B Investment Conference . During a media briefing on the second day of the event, Federal Health Minister Mustafa Kamal said on Saturday said 16 contracts and 80 memoranda of understanding had been finalised. He termed it a key economic milestone for cooperation between the two countries in the pharmaceutical sector. He said an environment had been created for local production of health equipment and investment in the country. Sharing details, Mr Kamal said contracts worth $600m and MoUs worth $250m had been signed. He said these included 18 agreements related to herbal medicines. He acknowledged growing business-to-business ties between Pakistani and Chinese firms and welcomed investment from Chinese companies...